Abstract:Some novel mixed ligand complexes incorporating 4N‐(4,6‐dimethylpyrimidin‐2‐yl)‐3a,4,5,6,7,7a‐hexahydro‐1H‐benzimidazol‐2‐amine and imidazole were synthesized, and their structures were elucidated by different physicochemical and computational techniques. Moreover, all the new compounds were tested in vitro against microbial strains, free radicals, and cancer cell lines. Furthermore, DNA interaction with the inspected complexes were investigated. This study was planned to prepare new mixed ligand chelates derived from N‐(4,6‐dimethylpyrimidin‐2‐yl)‐3a,4,5,6,7,7a‐hexahydro‐1H‐benzimidazol‐2‐amine (BIP), and imidazole (I). They identified through CHN study, spectroscopic (NMR, FT‐IR, and UV–Vis), conductivity, magnetic susceptibility, mass analysis, and thermal analysis. Correlation between all results exposed that the BIP ligand performed as a bi‐dentate ligand through NN donation locations, where the co‐ligand shows as N–H monodentate. The optimization for the studied chelates led to the formation of distorted octahedral geometry for BIPICu and BIPIVO chelates, distorted (tetrahedral and square planar) geometry for BIPIAg and BIPIPd chelates, respectively, around the metal salt. The B3LYP level, B3LYP/6‐311G** level for the free ligand, and B3LYP/6–311G**‐LANL2DZ functional level for the solid chelates were used in density functional theory (DFT) calculations. The findings showed that DFT calculations produce conclusions that are consistent with those of the experiments. The resulting compounds' nonlinear optical properties were examined by calculating the hyperpolarizability (β) and molecular polarizability (α) parameters, which gave rise to several unexpected optical properties for the synthesized compounds. Using the agar well diffusion method, the antimicrobial activity of the produced compounds was experimentally confirmed against a subset of G+ and G− bacteria. To ascertain how these substances attach to the targeted protein binding sites, a molecular docking mechanism between the microbially resistant chelates and their suppressed microbial protein pocket receptors was investigated. Also, DNA binding estimated for studied structures was tested by electronic absorption spectrum, viscosity estimation, and gel electrophoresis. Data proposed that all tested compounds link with DNA using an intercalation, electrostatic, and covalent binding mechanism. Moreover, antioxidant performance for studied compounds was governed by radical scavenging techniques in vitro. In addition, an MTT assay has been worked out to explore in vitro cytotoxic impending. All the tested chelates assumed antimicrobial, antitumor, and antioxidant performances that cause them to suggest drugs.

Crystal structure, Hirshfeld surface analysis, molecular modeling, electrochemical properties, and of a novel binuclear Co(II) complex

Crystal structure, DNA interaction, and antiproliferative activity of the cobalt(II) complex of demethylcantharate and imidazole

Bio-relevant Cobalt(ii) Complexes with Compartmental Polyquinoline Ligand: Synthesis, Crystal Structures and Biological Activities.

Synthesis, characterization, thermal, anticancer studies, and density functional theory for potentially active pyrimidine‐based complexes

Crystal Structure,Interaction with DNA and BSA and Antiproliferative Activities of Cobalt(Ⅱ) Complex with Demethylcantharate and 2-Aminopyridine

An In-Silico Drug Designing Approach Attempted on a Newly Synthesized Co(II) Complex along with its Other Biological Activities: A Combined Investigation of both Experimental and Theoretical Aspects

Synthesis and crystal structure determination of cobalt(II) mixed-ligand complex containing 1,10-phenanthroline and 5-(2-carboxybenzyloxy)isophthalic acid: Their biological evaluation viz. DNA/protein binding profile, pBR322 DNA cleavage activity

Synthesis, Characterization, Investigation of DNA Interactions and Biological Evaluation of Co(II), Ni(II), Cu(II) and Zn(II) Complexes with Newly Synthesized 2-methoxy 5-trifluoromethyl benzenamine Schiff Base

Synthesis, Crystal Structures, DNA Binding and Cleavage Properties and Protein Binding Activities of Three Mononuclear Cobalt(ii) Complexes

Synthesis, structural elucidation, and DNA binding behavior of a ternary copper(II) complex featuring substituted bipyridyl and dicarboxylate ligands

Innovation, structural inspection for new mixed complexes: DNA binding, biomedical applications and molecular docking approaches

Molecular docking and biological activities of Ni(II), Cu(II) and Co(II) complexes with a new potentially hexadentate polyamine ligand; X-ray crystal structure of the Cu(II) complex

Experimental and molecular modelling demonstration of effective DNA and protein binding as well as anticancer potential of two mononuclear Cu(II) and Co(II) complexes with isothiocyanate and azide as anionic residues

Novel Co2+ and Cd2+ Complexes Derived From a New N‐Donor Pyridyl‐Functionalized Thiophosphoric Triamide Ligand: Structural Investigation, DNA/COVID‐19/Monkeypox Molecular Docking, and Biological Assays

Synthesis, Spectroscopy, X-ray Structures, DNA Binding and Photocatalytic Properties of Two Ni(II) and Co(II) Complexes of a Pyrazolyl Schiff-base Ligand

Green processing and characterization of Novel HETERO-ligand Co(II) complexes with cyanopyridine derivatives: Quantitative structure, Computational assessment, and Biological activity relationship

Preparation, Characterization, DFT Calculations, Antibacterial and Molecular Docking Study of Co(II), Cu(II), and Zn(II) Mixed Ligand Complexes

Synthesis, characterization, biological potency, and molecular docking of Co2+, Ni2+ and Cu2+ complexes of a benzoyl isothiocyanate based ligand

Co (II), Ni (II), and Cu (II) ternary complexes with 2,6‐pyridinedicarboxylic acid: Thermal decomposition, DNA interaction, and biological activity studies

Synthesis and DNA interaction studies of Ni(II), Cu(II) and Co(II) complexes with a polyamine ligand containing homopiperazine; X-ray crystal structure of Cu(II) complex

Design, synthesize, physicochemical characterization, nonlinear optical properties structural elucidation, biomedical studies, and DNA interaction of some new mixed ligand complexes incorporating 4,6‐dimethylpyrimidine derivative and imidazole ligand